SB 73
Latest Information Update: 30 Aug 2001
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 Aug 2001 No-Development-Reported for HIV infections treatment in Brazil (Unknown route)